Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-037849

Options or other derivatives

  • Director acquired 41,841 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Giles Lisa M. Director 2022-06-15 Grant or award · Stock Option (Right to Buy) +41,841 41,841 D
Loading xslF345X03/doc4.xml…